As mentioned above, cases which acquire TET2 or DNMT3A mutations before the JAK2 mutation more often have an ET phenotype [35,88], and the two different types of CALR mutations are more balanced in ET vs. PMF [93]. Here, DNMT3A is linked to essential thrombocythemia.